Document:

Sale and Servicing Agreement

 Exhibit 10.1 
 EXECUTION VERSION 
 AMENDMENT NO. 1 
 TO THE 
 SALE AND SERVICING
AGREEMENT 
 Amendment No. 1, dated as of June 30, 2006 (the “Amendment”), to the Sale and Servicing
Agreement (the “Agreement”) dated as of April 1, 2006, by and among NovaStar Certificates Financing Corporation, as depositor (the “Depositor”), NovaStar Mortgage, Inc., as sponsor and servicer (the
“Sponsor” or “Servicer”), NovaStar Mortgage Funding Trust, Series 2006-1, as issuing entity (the “Issuing Entity”), U.S. Bank, National Association, as custodian (the “Custodian”),
JPMorgan Chase Bank, National Association, as indenture trustee (the “Indenture Trustee”) and J.P. Morgan Trust Company, National Association, as co-trustee (the “Co-Trustee”). Capitalized terms used and not defined
herein shall have the meaning set forth in the Agreement and Appendix I thereto. 
 WHEREAS the parties hereto have entered into the
Agreement; 
 WHEREAS the parties hereto now wish to amend certain provisions in the Agreement pursuant to Section 11.03 of the
Agreement; and 
 WHEREAS the Indenture Trustee shall not consent to this Amendment to the Agreement unless it shall have first received an
Opinion of Counsel, to the effect that (a) this Amendment (i) will not prevent the Notes from being characterized as debt for United States federal income tax purposes or cause the Issuing Entity to be subject to an entity-level tax for
federal income tax purposes, and (ii) shall not adversely affect in any material respect the interests of any Noteholder or the Hedge Counterparties, and (b) any applicable requirements and conditions set forth in the Agreement with
respect to the adoption of amendments thereto have been complied with. 
 NOW, THEREFORE, in consideration of the promises and mutual
agreements contained herein, the parties hereto agree to amend the Agreement pursuant to Section 11.03 of the Agreement and restate certain provisions thereof as follows: 
 1. The Amendment. 
 (a)
Section 4.01 is hereby amended to include the following language: 
 (ciii) With respect to any second lien Group I Mortgage Loan, such
lien is on a one-to four-family residence that is the principal residence of the borrower; 
 (civ) No second lien Group I Mortgage Loan has
an original principal balance that exceeds one-half of the one-unit limitation for first lien mortgage loans, or $208,500 (in Alaska, Guam, Hawaii or Virgin Islands: $312,750), without regard to the number of units; and 

 (cv) With respect to the Group I Mortgage Loans, the original principal balance of the first lien
mortgage loan plus the original principal balance of any subordinate lien mortgage loans relating to the same mortgaged property does not exceed the applicable Freddie Mac loan limit for first lien mortgage loans for that property type (as set out
in herein at Section 4.01(lxxix)). 
 2. Condition to effectiveness. As a condition to the effectiveness of this Amendment, an
Opinion of Counsel satisfying the requirements of Section 11.03 of the Agreement has been received by the Parties hereto. 
 3.
Effect of Amendment. This Amendment to the Agreement shall be effective and the Agreement shall be deemed to be modified and amended in accordance herewith on the Distribution Date on the date on which the Indenture Trustee receives an
executed copy of this Amendment. This Amendment, once effective, shall be effective as of the date first set forth above. The respective rights, limitations, obligations, duties, liabilities and immunities of the Depositor, the Sponsor, the
Servicer, the Issuing Entity, the Custodian, the Co-Trustee and the Indenture Trustee shall hereafter be determined, exercised and enforced subject in all respects to such modifications and amendments, and all the terms and conditions of this
Amendment shall be and be deemed to be part of the terms and conditions of the Agreement for any and all purposes. The Agreement, as amended hereby, is hereby ratified and confirmed in all respects. 
 4. The Agreement in Full Force and Effect as Amended. Except as specifically amended hereby, all the terms and conditions of the Agreement shall
remain in full force and effect and, except as expressly provided herein, the effectiveness of this Amendment shall not operate as, or constitute a waiver or modification of, any right, power or remedy of any party to the Agreement. All references
to the Agreement in any other document or instrument shall be deemed to mean the Agreement as amended by this Amendment. 
 5.
Counterparts. This Amendment may be executed by the Parties in several counterparts, each of which shall be deemed to be an original and all of which shall constitute together but one and the same agreement. This Amendment shall become
effective when counterparts hereof executed on behalf of such Party shall have been received. 
 6. Governing Law. This Amendment
shall be construed in accordance with and governed by the laws of the State of New York applicable to agreements made and to be performed therein. 
 7. Limitation of Owner Trustee Liability. It is expressly understood and agreed by the parties that (a) this document is executed and delivered by Wilmington Trust Company, not individually or personally, but solely as Owner
Trustee, in the exercise of the powers and authority conferred and vested in it, pursuant to the Trust Agreement, (b) each of the representations, undertakings and agreements herein made on the part of the Issuing Entity is made and intended
not as personal representations, undertakings and agreements by Wilmington Trust Company but is made and intended for the purpose for binding only the Issuing Entity, (c) nothing herein contained shall be construed as creating any liability on
Wilmington Trust Company, individually or personally, to perform any covenant either expressed or implied contained herein, all such liability, if any, being expressly waived by the parties hereto and by any person claiming by, through or under the
parties hereto, and (d) under no circumstances shall Wilmington Trust Company be personally liable for the payment of any indebtedness or expenses of the Issuing Entity or be liable for the breach or failure of any obligation, representation,
warranty or covenant made or undertaken by the Issuing Entity under this Amendment or any other related documents. 
  

 2 

 IN WITNESS WHEREOF, the Depositor, Sponsor, the Servicer, the Issuing Entity, the Indenture Trustee, the
Co-Trustee and the Custodian, have caused this Amendment to be duly executed by their officers thereunto duly authorized, all as of the day and year first above written. 
  

			
	NOVASTAR CERTIFICATES FINANCING CORPORATION, as Depositor
		
	By:	 	 /s/ Matt Kaltenrieder

	Name:	 	Matt Kaltenrieder
	Title:	 	Vice President
	
	 NOVASTAR MORTGAGE, INC.,
 as Sponsor and as
Servicer

		
	By:	 	 /s/ Matt Kaltenrieder

	Name:	 	Matt Kaltenrieder
	Title:	 	Vice President
	
	NOVASTAR MORTGAGE FUNDING TRUST, SERIES 2006-1, as Issuing Entity
	
	By: WILMINGTON TRUST COMPANY, not in its individual capacity, but solely as Owner Trustee under the Trust Agreement
		
	By:	 	 /s/ Ian P. Monigle

	Name:	 	Ian P. Monigle
	Title:	 	Administrative Account Manager, Authorized Signer
	
	U.S. BANK, NATIONAL ASSOCIATION, as Custodian
		
	By:	 	 /s/ Ronald L. Fisher

	Name:	 	Ronald L. Fisher
	Title:	 	Vice President

 [Signature Page for Amendment No. 1 to the Sale and Servicing Agreement] 
  

 3 

							
		 		  	JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, not in its individual capacity but solely as Indenture Trustee
				
		 		  	By:	 	 /s/ Andrew M. Cooper

		 		  	Name:	 	Andrew M. Cooper
		 		  	Title:	 	Assistant Vice President
			
		 		  	J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, as Co-Trustee
				
		 		  	By:	 	 /s/ Mark W. McDermott

		 		  	Name:	 	Mark W. McDermott
		 		  	Title:	 	Vice President
			
	NOVASTAR FINANCIAL, INC., solely with respect to Section 4.01	  		 	
				
	By:	 	 /s/ Matt Kaltenrieder
	  		 	
	Name:	 	Matt Kaltenrieder	  		 	
	Title:	 	Vice President	  		 	

 [Signature Page for Amendment No. 1 to the Sale and Servicing Agreement] 
  

 4Underwriting Agreement

 Exhibit 10.1 
 NEW CENTURY BANCORP, INC. 
 1,000,000
Shares of Common Stock* 
 UNDERWRITING AGREEMENT 
 June 29, 2006 
 Howe Barnes Investments, Inc. 

    As Representative of the Several Underwriters 
             named in Schedule I hereto 
 222 South Riverside Plaza 
 7th
Floor 
 Chicago, Illinois 60606 
 Ladies and Gentlemen: 
 New
Century Bancorp, Inc., a North Carolina corporation (the “Company”), has authorized capital stock consisting of 10,000,000 shares of common stock, $1.00 par value (“Common Stock”), of which 4,241,040 shares were outstanding as of
December 31, 2005. The Company proposes, subject to the terms and conditions stated herein, to issue and sell 1,000,000 shares of its authorized but unissued Common Stock (the “Firm Shares”) to the several underwriters named in
Schedule I hereto as it may be amended by the Pricing Agreement hereinafter defined (the “Underwriters”), who are acting severally and not jointly and for whom Howe Barnes Investments, Inc. is acting as representative (the
“Representative”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to 150,000 additional shares of Common Stock (“the Optional Shares”) (the Firm Shares and the Optional Shares that the
Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares”). 
 The
Representative has advised the Company that the Underwriters propose to make a public offering of their respective portions of the Shares as soon as the Representative deems advisable after the registration statement hereinafter referred to becomes
effective, if it has not yet become effective, and the Pricing Agreement hereinafter defined has been executed and delivered. 
 Prior to the
purchase and public offering of the Shares by the Underwriters, the Company and the Representative shall enter into an agreement substantially in the form of Exhibit A hereto (the “Pricing Agreement”). The Pricing Agreement may take
the form of an exchange of any standard form of written communication between the Company and the Representative and shall 
  

	*	Plus an option to acquire up to 150,000 additional shares to cover overallotments. 

 specify such applicable information as is indicated in Exhibit A hereto. The offering of the Shares will be governed by
this Agreement, as supplemented by the Pricing Agreement. From and after the date of the execution and delivery of the Pricing Agreement, this Agreement shall be deemed to incorporate the Pricing Agreement. 
 1. (a) The Company represents and warrants to, and agrees with, each of the Underwriters that: 
 (i) A registration statement on Form S-1 (File No. 333-134182) (the “Initial Registration Statement”) in respect of the Shares has been
filed with the Securities and Exchange Commission (the “Commission”); the Initial Registration Statement and any post-effective amendment thereto, each in the form heretofore delivered to Representative, and, excluding exhibits thereto,
for each of the other Underwriters, have been declared effective by the Commission in such form; other than a registration statement, if any, increasing the size of the offering (a “Rule 462(b) Registration Statement”), filed pursuant to
Rule 462(b) under the Securities Act of 1933, as amended (the “Act”), which became effective upon filing, no other document with respect to the Initial Registration Statement has heretofore been filed with the Commission; the Company has
complied to the Commission’s satisfaction with all requests of the Commission for additional or supplemental information; and no stop order suspending the effectiveness of the Initial Registration Statement, any post-effective amendment
thereto, or the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose has been initiated or threatened by the Commission (any preliminary prospectus included in the Initial Registration Statement or filed
with the Commission pursuant to Rule 424(a) of the rules and regulations of the Commission under the Act, is hereinafter called a “Preliminary Prospectus”; the various parts of the Initial Registration Statement and the Rule 462(b)
Registration Statement, if any, including all exhibits thereto and including the information contained in the form of final prospectus filed with the Commission pursuant to Rule 424(b) under the Act in accordance with Section 5(a) hereof and
deemed by virtue of Rule 430A under the Act to be part of the Initial Registration Statement at the time it was declared effective, each as amended at the time such part of the Initial Registration Statement became effective or such part of the Rule
462(b) Registration Statement, if any, became or hereafter becomes effective, are hereinafter collectively called the “Registration Statement”; and such final prospectus, in the form first filed pursuant to Rule 424(b) under the Act, is
hereinafter called the “Prospectus”); 
 (ii) No order preventing or suspending the use of any Preliminary Prospectus has been
issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof, conformed in all material respects to the requirements of the Act and the rules and regulations of the Commission thereunder, and did not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that
this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the Representative expressly for use therein;

  

 - 2 - 

 (iii) The Registration Statement conforms, and the Prospectus and any further amendments or supplements
to the Registration Statement or the Prospectus will conform, in all material respects to the requirements of the Act and the rules and regulations of the Commission thereunder; on the effective date and at any Time of Delivery (as defined in
Section 5 hereof), the Registration Statement did not or will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not
misleading; and when filed and at any Time of Delivery, the Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through the Representative expressly for use therein. Each Preliminary Prospectus and the Prospectus when filed, if filed by electronic transmission, pursuant to EDGAR (except as may
be permitted by Regulation S-T under the Act), was identical to the copy thereof delivered to the Underwriters for use in connection with the offer and sale of the Shares; 
 (iv) As of the Applicable Time, neither (i) any Issuer-Represented General Use Free Writing Prospectuses issued at or prior to the Applicable Time
and the Statutory Prospectus, all considered together (collectively, the “General Disclosure Package”), nor (ii) any individual Issuer-Represented Limited-Use Free Writing Prospectus issued at or prior to the Applicable Time, when
considered together with the General Disclosure Package, included any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an
Underwriter through the Representative expressly for use therein. As used in this paragraph and elsewhere in this Agreement: 
 “Applicable Time” means 4:00 p.m. (Chicago time) on the date of this Agreement. 
 “Statutory Prospectus” as of
any time means the most recent Preliminary Prospectus that is included in the Registration Statement immediately prior to the Applicable Time. 
 “Issuer-Represented Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 under the Act, relating to the Shares in the form filed or required to be filed with the Commission or, if
not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) under the Act. 
 “Issuer-Represented General Use Free Writing Prospectus” means any Issuer-Represented Free Writing Prospectus that is intended for general distribution to prospective investors. 
  

 - 3 - 

 “Issuer-Represented Limited-Use Free Writing Prospectus” means any Issuer-Represented Free
Writing Prospectus that is not an Issuer-Represented General Use Free Writing Prospectus; 
 (v) Each Issuer-Represented Free Writing
Prospectus, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Shares or until any earlier date that the Company notified or notifies the Representative as described in Section 6(b), did
not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement; provided, however, that this representation and warranty shall not apply to
any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the Representative expressly for use therein; 
 (vi) Neither the Company nor any of its subsidiaries has sustained since the date of the latest audited financial statements included in each of the
General Disclosure Package and the Prospectus any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or
decree, otherwise than as set forth or contemplated in each of the General Disclosure Package and the Prospectus; and since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package and the
Prospectus, except as set forth or contemplated in the each of the General Disclosure Package and the Prospectus, (A) there has not been any material adverse change in the capital stock or long-term debt of the Company or any of its
subsidiaries or any material adverse change, or any development involving a prospective material adverse change, in or affecting the general affairs, management, business prospects, financial position, stockholders’ equity or results of
operations of the Company and its subsidiaries taken as a whole (a “Material Adverse Effect”), (B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of
business, which are material with respect to the Company and its subsidiaries, taken as a whole, and (C) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock; 

(vii) The Company and its subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all
personal property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in each of the General Disclosure Package and the Prospectus or such as do not materially affect the value of such
property and do not interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid,
subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries; 
 (viii) The Company is a registered bank holding company under the Bank Holding Company Act of 1956, as amended and has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the State of North Carolina, with 
  

 - 4 - 

 power and authority (corporate and other) to own its properties and conduct its business as described in each of the
General Disclosure Package and the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts
any business so as to require such qualification, except where the failure to so qualify or be in good standing does not have, and could not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; 
 (ix) Each subsidiary of the Company either has been duly incorporated and is validly existing as a corporation or Delaware statutory trust, as the case
may be, in good standing under the laws of their respective places of incorporation or organization, as the case may be, and with respect to the Company’s banking subsidiaries, New Century Bank and New Century Bank South, (the
“Banks”) have been duly chartered and are validly existing as North Carolina-chartered commercial banks, in each case in good standing under the laws of the jurisdiction of its organization, with power and authority (corporate and other)
to own its properties and conduct its business as described in each of the General Disclosure Package and the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of
each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except where the failure to so qualify or be in good standing does not have, and could not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect; the deposit accounts of the Banks are insured up to the applicable limits by the Federal Deposit Insurance Corporation (the “FDIC”); all of the issued shares of capital stock of
each subsidiary of the Company have been duly authorized and validly issued and are fully paid and nonassessable, except to the extent set forth in N.C. Gen. Stat. § 53-42 and are owned, directly or through other subsidiaries of the Company, by
the Company, free and clear of any pledge, lien, encumbrance, claim or equity; and the Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21.1 to the
Registration Statement; 
 (x) The Company has an authorized capitalization as set forth in each of the General Disclosure Package and the
Prospectus under the caption “Capitalization,” and all of the issued shares of capital stock of the Company have been duly and validly authorized and issued, are fully paid and nonassessable and have been issued in compliance with federal
and state securities laws and conform to the description of the Shares contained in each of the General Disclosure Package and the Prospectus; and no such shares were issued in violation of the preemptive or similar rights of any security holder of
the Company; and no person has any preemptive or similar right to purchase any shares of capital stock or equity securities of the Company; 
 (xi) The unissued Shares to be issued and sold by the Company to the Underwriters hereunder have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued
and fully paid and nonassessable and will conform to the description of the Shares contained in each of the General Disclosure Package and the Prospectus; 
  

 - 5 - 

 (xii) Except as described in each of the General Disclosure Package and the Prospectus, (A) there
are no outstanding rights (contractual or otherwise), warrants or options to acquire, or instruments convertible into or exchangeable for, or agreements or understandings with respect to the sale or issuance of, any shares of capital stock of or
other equity interest in the Company and (B) there are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement under the Act or
otherwise register any securities of the Company owned or to be owned by such person; 
 (xiii) The issue and sale of the Shares by the
Company and the compliance by the Company and the Banks with all of the provisions of this Agreement, the Pricing Agreement and the consummation of the transactions therein contemplated will not conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, any contract, indenture, mortgage, deed of trust, loan agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which
the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject (collectively, the “Agreements and Instruments”), nor will any such action (A) result in
any violation of the provisions of the articles of incorporation or charter (as applicable) or bylaws of the Company or any of its subsidiaries or any law, statute or any order, rule or regulation of any federal, state, local or foreign court,
arbitrator, regulatory authority or governmental agency or body (each, a “Governmental Entity”) having jurisdiction over the Company or any of its subsidiaries or any of their properties or (B) constitute a Repayment Event (as defined
below) under, or result in the creation or imposition of any lien, charge or other encumbrance upon any assets or operations of the Company or any subsidiary pursuant to, any of the Agreements and Instruments; and no consent, approval,
authorization, order, registration or qualification of or with any such Governmental Entity is required for the issue and sale of the Shares or the consummation by the Company of the transactions contemplated by this Agreement, except the
registration under the Act and the Securities Exchange Act of 1934, as amended (the “1934 Act”), of the Shares, as may be required under the rules and regulations of the National Association of Securities Dealers, Inc. (“NASD”)
and such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Underwriters. As used herein, a
“Repayment Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment
of all or a portion of such indebtedness by the Company or any subsidiary; 
 (xiv) Neither the Company nor any of its subsidiaries is
(A) in violation of its articles of incorporation or charter, as applicable, or bylaws or (B) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any of the Agreements and
Instruments, except with respect to subsection (B) for such default that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; 
  

 - 6 - 

 (xv) The statements set forth in each of the General Disclosure Package and the Prospectus under the
caption “Description of Our Securities,” insofar as they purport to constitute a summary of the terms of the capital stock of the Company, and under the caption “Supervision and Regulation” insofar as they purport to describe the
provisions of the laws and documents referred to therein, are accurate and complete; 
 (xvi) The financial statements included in each of
the Registration Statement, the General Disclosure Package and the Prospectus, together with the supporting schedules, if any, and notes, present fairly the consolidated financial condition of the Company and its subsidiaries at the dates indicated
and the consolidated results of operations and cash flows of the Company and its subsidiaries for the periods specified. Such financial statements and supporting schedules, if any, have been prepared in conformity with generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the periods involved. The selected financial data and the summary financial information included in each of the Registration Statement, the General Disclosure Package and the
Prospectus present fairly the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included in the Registration Statement, the General Disclosure Package and the Prospectus; 

(xvii) Each of the Company and its subsidiaries maintains a system of accounting controls sufficient to provide reasonable assurances that
(A) transactions are executed in accordance with management’s general or specific authorization, (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (C) access to assets is permitted only in accordance with the management’s general or specific authorization and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences; 
 (xviii) The Company has established and maintains disclosure controls
and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Act). Such disclosure controls and procedures (A) are designed to ensure that material information relating to the Company, including its consolidated
subsidiaries, is made known to the Company’s chief executive officer and its chief financial officer by others within those entities to allow timely decisions regarding disclosures, (B) have been evaluated for effectiveness as of the end
of the most recent fiscal quarter and (C) are effective to perform the functions for which they were established. The Company’s independent registered public accounting firm and the Audit Committee of the Board of Directors of the Company
have been advised of (1) any significant deficiencies or material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process,
summarize, and report financial data and (2) any fraud, whether or not material, that involves management or other employees who have a role in the Company’s internal control over financial reporting. Since the date of the most recent
evaluation of such disclosure controls and procedures, there have been no changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect the Company’s internal control over
financial reporting; 
  

 - 7 - 

 (xix) Neither the Company nor any of its subsidiaries is subject or is party to, or has received any
notice or advice that any of them may become subject or party to any investigation with respect to, any corrective, suspension or cease-and-desist order, agreement, consent agreement, memorandum of understanding or other regulatory enforcement
action, proceeding or order with or by, or is a party to any commitment letter or similar undertaking to, or is subject to any directive by, or has been a recipient of any supervisory letter from, or has adopted any board resolutions at the request
of, any Regulatory Agency (as defined below) that currently relates to or restricts in any material respect the conduct of their business or that in any manner relates to their capital adequacy, credit policies or management (each, a
“Regulatory Agreement”), nor has the Company or any of its subsidiaries been advised by any Regulatory Agency that it is considering issuing or requesting any such Regulatory Agreement. There is no unresolved violation, criticism or
exception by any Regulatory Agency with respect to any report or statement relating to any examinations of the Company or any of its subsidiaries which, in the reasonable judgment of the Company, is expected to result in a Material Adverse Effect.
As used herein, the term “Regulatory Agency” means any Governmental Entity having supervisory or regulatory authority with respect to the Company or any of its subsidiaries, including, but not limited to, any federal or state agency
charged with the supervision or regulation of depositary institutions or holding companies of depositary institutions, or engaged in the insurance of depositary institution deposits; 
 (xx) Except as disclosed in each of the General Disclosure Package and the Prospectus, the Company and its subsidiaries are conducting their respective
businesses in compliance with all statutes, laws, rules, regulations, judgments, decisions, directives, orders and decrees of any Governmental Entity (including, without limitation, all regulations and orders of, or agreements with, the North
Carolina Commissioner of Banks, the Board of Governors of Federal Reserve System (the “FRB”) and the FDIC) applicable to them, except where the failure to so comply would not reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect; 
 (xxi) Other than as set forth in each of the General Disclosure Package and the Prospectus, there are no
legal or governmental actions, suits, investigations or proceedings before or by any Governmental Entity, now pending or, to the best of the Company’s knowledge, threatened or contemplated by Governmental Entities or threatened by others, to
which the Company or any of its subsidiaries is a party or of which any property or asset of the Company or any of its subsidiaries is the subject (A) that are required to be disclosed in the Registration Statement by the Act or by the rules
and regulations of the Commission thereunder and not disclosed therein or (B) which, if determined adversely to the Company or any of its subsidiaries, would, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect; and there are no contracts or documents of the Company or any of its subsidiaries that are required to be described in the Registration Statement or to be filed as exhibits thereto by the Act or by the rules and regulations of the Commission
thereunder which have not been so described and filed; 
 (xxii) Each of the Company and its subsidiaries possess such permits, licenses,
approvals, consents and other authorizations (collectively, “Governmental 
  

 - 8 - 

 Licenses”) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies necessary to
conduct the business now operated by the Company or its subsidiaries; the Company and its subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where the failures so to comply would not, singly or in
the aggregate, reasonably be expected to have a Material Adverse Effect; all of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental Licenses or the failure of such Governmental Licenses
to be in full force and effect would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the
revocation or modification of any such Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect; 
 (xxiii) Each of the Company and its subsidiaries is in compliance with all applicable federal, state and local environmental laws and regulations,
including, without limitation, those applicable to emissions to the environment, waste management, and waste disposal (each an “Environmental Law”), except where such noncompliance would not reasonably be expected to have a Material
Adverse Effect, or except as disclosed in each of the General Disclosure Package and the Prospectus, and to the knowledge of the Company, there are no circumstances that would prevent, interfere with or materially increase the cost of such
compliance in the future; 
 (xxiv) To the knowledge of the Company, under applicable law, there are no past or present actions, activities,
circumstances, events or incidents, including, without limitation, releases of any material into the environment, that are reasonably likely to form the basis of any claim under any Environmental Law, including common law, against the Company or its
subsidiaries which would be reasonably likely to have a Material Adverse Effect; 
 (xxv) The statistical and market related data contained
in each of the General Disclosure Package, the Prospectus or the Registration Statement are based on or derived from sources which the Company believes are reliable and accurate; 
 (xxvi) This Agreement and the Pricing Agreement have been duly authorized, executed and delivered by the Company; 
 (xxvii) Neither the Company nor any affiliate of the Company nor any person acting on their behalf has taken, nor will the Company or any affiliate or
any person acting on their behalf take, directly or indirectly, any action which is designed to or which has constituted or which would be expected to cause or result in stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares; 
 (xxviii) The Company is not and, after giving effect to the offering and sale of the Shares,
and after receipt of payment for the Shares and the application of such proceeds as described in each of the General Disclosure Package and the Prospectus, will not be an “investment company” or an entity “controlled” by an
“investment company”, as such terms are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”); 
  

 - 9 - 

 (xxix) Neither the Company nor any of its affiliates does business with the government of Cuba or with
any person or affiliate located in Cuba within the meaning of Section 517.075, Florida Statutes; 
 (xxx) Dixon Hughes PLLC, who have
certified the financial statements and supporting schedules of the Company and its subsidiaries, included in the Registration Statement, the General Disclosure Package and the Prospectus is an independent registered public accounting firm as
required by the Act and the rules and regulations of the Commission thereunder, and such accountants are not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 with respect to the Company; 
 (xxxi) No labor problem or dispute with the employees of the Company or any of its subsidiaries exists or, to the Company’s knowledge, is
threatened or imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries’ principal suppliers, contractors or customers, that could have a Material Adverse Effect,
whether or not arising from transactions in the ordinary course of business, except as set forth in each of the General Disclosure Package and the Prospectus; 
 (xxxii) The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the business in which
they are engaged; all policies of insurance insuring the Company or any of its subsidiaries are in full force and effect; the Company and its subsidiaries are in compliance with the terms of such policies and instruments in all material respects;
and there are no claims by the Company or any of its subsidiaries under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; neither the Company nor any such
subsidiary has been refused any insurance coverage sought or applied for; and neither the Company nor any such subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect, except as set forth or contemplated in each of the General Disclosure Package and the
Prospectus; 
 (xxxiii) The Company has filed all foreign, federal, state and local tax returns that are required to be filed or is eligible
for, and has requested, extensions thereof, except as set forth or contemplated in each of the General Disclosure Package and the Prospectus and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against
it, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith or as would not have a Material Adverse Effect, except as set forth or contemplated in
each of the General Disclosure Package and the Prospectus; 
  

 - 10 - 

 (xxxiv) New Century Bank is not currently prohibited, directly or indirectly, from paying any dividends
to the Company, from making any other distribution on its capital stock and no subsidiary of the Company is prohibited, directly or indirectly, from repaying to the Company any loans or advances to such subsidiary from the Company or from
transferring any of such subsidiary’s property or assets to the Company or any other subsidiary of the Company, except as set forth or contemplated in each of the General Disclosure Package and the Prospectus; 
 (xxxv) Any “employee benefit plan” (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and
published interpretations thereunder (collectively, “ERISA”)) established or maintained by the Company, any of the subsidiaries or their “ERISA Affiliates” (as defined below) is in compliance in all material respects with ERISA;
“ERISA Affiliate” means, with respect to the Company or any subsidiary, any member of any group of organizations described in Section 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the
regulations and published interpretations thereunder (the “Code”) of which the Company or such subsidiary is a member; no “reportable event” (as defined under ERISA) has occurred or is reasonably expected to occur with respect to
any “employee benefit plan” established or maintained by the Company, any of the subsidiaries or any of their ERISA Affiliates; no “employee benefit plan” established or maintained by the Company, any of the subsidiaries or any
of their ERISA Affiliates, if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined under ERISA); none of the Company, its subsidiaries nor any of their ERISA Affiliates
has incurred or reasonably expects to incur any liability under (A) Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (B) Sections 412, 4971, 4975 or 4980B of the Code; each
“employee benefit plan” established or maintained by the Company, any of the subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred
whether by action or failure to act, which would cause the loss of such qualification; 
 (xxxvi) Except as would not reasonably be expected
to have a Material Adverse Effect, the Company and its subsidiaries own, or have valid, binding enforceable and sufficient licenses or other rights to use the patents and patent applications, copyrights, trademarks, service marks, trade names,
technology, know-how (including trade secrets and other unpatented and/or unpatentable proprietary rights) and other intellectual property necessary or used in any material respect to conduct their business in the manner in which it is being
conducted and in the manner in which it is contemplated as set forth in each of the General Disclosure Package and the Prospectus or otherwise necessary or used in connection with the commercialization of the existing products of the Company and its
subsidiaries and the products described in each of the General Disclosure Package and the Prospectus as being under development (collectively, the “Company Intellectual Property”); except as would not reasonably be expected to have a
Material Adverse Effect, the Company Intellectual Property is valid, subsisting and enforceable, and none of the patents owned or licensed by the Company or any of its subsidiaries is unenforceable or invalid, and none of the patent applications
owned or licensed by the Company or any of its subsidiaries would be unenforceable or invalid if issued as patents; the Company and its subsidiaries, and to the Company’s knowledge, their licensors, 
  

 - 11 - 

 have complied with the duty of candor and disclosure of the U.S. Patent and Trademark Office and any similar foreign
intellectual property office (collectively, the “Patent Offices”); to the best knowledge of the Company, neither the Company nor its subsidiaries have infringed or otherwise violated any intellectual property rights of any third person or
have breached any contract in connection with which any Company Intellectual Property is provided to the Company and its subsidiaries where such infringement would reasonably be expected to have a Material Adverse Effect; neither the Company nor any
of its subsidiaries is obligated to pay a royalty, grant a license, or provide other consideration to any third party in connection with the Company Intellectual Property other than as disclosed in each of the General Disclosure Package and the
Prospectus; no person has asserted or threatened to assert any claim against, or notified, the Company (or any of its subsidiaries) that (A) the Company or any of its subsidiaries has infringed or otherwise violated any intellectual property
rights of any third person, (B) the Company or any of its subsidiaries is in breach or default of any contract under which any Company Intellectual Property is provided, (C) such person will terminate a contract described in clause
(B) or adversely alter the scope of the rights provided thereunder or (D) otherwise concerns the ownership, enforceability, validity, scope, registerability, interference, use or the right to use, any Company Intellectual Property (other
than a patent office review of pending applications in the ordinary course); to the knowledge of the Company no third party is infringing or otherwise violating any of the Company Intellectual Property owned by the Company or any of its
subsidiaries, except as would not reasonably be expected to have a Material Adverse Effect; 
 (xxxvii) Neither the Company nor any of its
subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or other person associated with or acting on behalf of the Company or any of its subsidiaries has (A) used any Company funds for any unlawful
contribution, gift, entertainment or other unlawful expenses relating to political activity; (B) made any direct or indirect unlawful payment of Company funds to any foreign or domestic government official or employee; (C) violated or is
in violation of any provision of the Foreign Corrupt Practices Act of 1977 with regard to the Company or its subsidiaries; (D) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment with regard to Company funds or
activities; or (E) made any payment of funds to the Company or any of its subsidiaries or received or retained funds from the Company or any of its subsidiaries in violation of any law, rule or regulation, which payment, receipt or retention of
funds is of a character required to be disclosed in each of the General Disclosure Package and the Prospectus, that is not described in each of the General Disclosure Package and the Prospectus as required; 
 (xxxviii) The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened; 
  

 - 12 - 

 (xxxix) No relationship, direct or indirect, exists between or among the Company or any of its
subsidiaries, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other, that is required by the Act to be described in each of the General Disclosure Package and the
Prospectus and that is not so described; 
 (xl) Except as described in each of the General Disclosure Package and the Prospectus, there are
no material off-balance sheet transactions, arrangements, obligations (including contingent obligations), or any other relationships with unconsolidated entities or other persons, that may have a material current or future effect on the
Company’s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses; 
 (xli) The Company is in compliance with the provisions of the Sarbanes-Oxley Act and the rules and regulations of the Commission thereunder applicable
to it and will comply with those provisions of the Sarbanes-Oxley Act that will become effective in the future upon their effectiveness; and the Company is in compliance with the applicable rules and regulations of the Nasdaq National Market;

 (xlii) There is no material contract or other document of a character required to be described in the General Disclosure Package and the
Prospectus or to be filed as an exhibit to the Registration Statement which is not described or filed as required; 
 (xliii) All offers and
sales of the Company’s capital stock were exempt from the registration requirements of, or duly registered under, the Act and were duly registered with or the subject of an available exemption from the registration requirements of the
applicable state securities or blue sky laws; 
 (xliv) None of the Company, any of its subsidiaries or, to the knowledge of the Company,
any director, officer, agent, employee or Affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”),
and the Company will not knowingly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of
financing the activities of any person currently subject to any U.S. sanctions administered by OFAC; 
 (xlv) No statement, representation,
warranty or covenant made by the Company in this Agreement or made in any certificate or document required by this Agreement to be delivered to you was or will be, when made, inaccurate, untrue or incorrect; 
 (xlvi) Neither the Company nor its subsidiaries nor, to the Company’s knowledge, any employee or agent of the Company or its subsidiaries has made
any payment of funds of the Company or its subsidiaries or received or retained any funds in violation of any law, rule or regulation; and 
  

 - 13 - 

 (xlvii) At the time of filing the Registration Statement relating to the Shares and at the date hereof,
the Company was not and is not an “ineligible issuer,” as defined in Rule 405, including the Company or any of its subsidiaries in the preceding three years not having been convicted of a felony or misdemeanor or having been made the
subject of a judicial or administrative decree or order as described in Rule 405. 
 (b) The Banks represent and warrant to, and agree with,
each of the Underwriters that: 
 (i) The Banks have been duly chartered and are validly existing in good standing under the laws of the
state of North Carolina, with power and authority (corporate and other) to own their properties and conduct their business as described in each of the General Disclosure Package and the Prospectus, and have been duly qualified as foreign
corporations for the transaction of business and are in good standing under the laws of each other jurisdiction in which they own or lease properties or conduct any business so as to require such qualification, or are subject to no material
liability or disability by reason of the failure to be so qualified in any such jurisdiction; 
 (ii) Neither the Banks nor any of their
subsidiaries are in violation of their respective charter, bylaws or other charter documents or in default in the performance or observance of any material obligation, agreement, covenant or condition contained in any contract, indenture, mortgage,
deed of trust, loan agreement, note, lease or other agreement or instrument to which the Banks or any of their subsidiaries are a party or by which they or any of them may be bound, or to which any of the property of the Banks or any of their
subsidiaries is subject; and 
 (iii) The execution, delivery and performance of this Agreement and the Pricing Agreement by the Banks and
the compliance by the Banks with all of the provisions of this Agreement and the Pricing Agreement and the consummation of the transactions therein contemplated will not conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Banks or any of their subsidiaries are a party or by which the Banks or any of their subsidiaries are
bound or to which any of the property or assets of the Banks or any of their subsidiaries are subject, nor will such action result in any violation of the provisions of the charter of the Banks or any statute or any order, rule or regulation of any
court or governmental agency or body having jurisdiction over the Banks or any of their subsidiaries or any of their properties. 
 2. The
Representative, on behalf of the several Underwriters, represents and warrants to the Company that the information set forth (a) on the cover page of the Prospectus with respect to price, underwriting discount and terms of the offering,
(b) the legends concerning 
  

 - 14 - 

 stabilizing and passive market making activities on the inside front cover page of the Prospectus, and (c) under
“Underwriting” in the Prospectus was furnished in writing to the Company by and on behalf of the Underwriters specifically for use in connection with the preparation of the Registration Statement and is correct and complete in all material
respects. 
 3. Subject to the terms and conditions herein set forth, (a) the Company agrees to issue and sell to each of the
Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a purchase price per share set forth in the Pricing Agreement, the number of Firm Shares set forth opposite the name of such Underwriter
in Schedule I hereto and (b) in the event and to the extent that the Underwriters shall exercise the election to purchase Optional Shares as provided below, the Company agrees to issue and sell to each of the Underwriters, and each of the
Underwriters agrees, severally and not jointly, to purchase from the Company, at the purchase price per share set forth in the Pricing Agreement, that portion of the number of Optional Shares as to which such election shall have been exercised (to
be adjusted by you so as to eliminate fractional shares) determined by multiplying such number of Optional Shares by a fraction, the numerator of which is the maximum number of Optional Shares which such Underwriter is entitled to purchase as set
forth opposite the name of such Underwriter in Schedule I hereto and the denominator of which is the maximum number of Optional Shares that all of the Underwriters are entitled to purchase hereunder. 
 The Company hereby grants to the Underwriters the right to purchase at their election up to 150,000 Optional Shares, at the purchase price per share set
forth in the Pricing Agreement, for the sole purpose of covering overallotments in the sale of the Firm Shares. Any such election to purchase Optional Shares may be exercised only by written notice from the Representative to the Company, given
within a period of 30 calendar days after the date of this Agreement, setting forth the aggregate number of Optional Shares to be purchased and the date on which such Optional Shares are to be delivered, as determined by the Representative but in no
event earlier than the First Time of Delivery (as defined in Section 5 hereof) or, unless the Representative and the Company otherwise agree in writing, earlier than two or later than ten business days after the date of such notice. 

It is understood that each Underwriter has authorized the Representative for such Underwriter’s account, to accept delivery of, receipt for, and
make payment of the purchase price for, the Firm Shares and the Optional Shares, if any, which such Underwriter has agreed to purchase. Howe Barnes Investments, Inc., individually and not as representative of the Underwriters, may (but shall not be
obligated to) make payment of the purchase price for the Firm Shares or the Optional Shares, if any, to be purchased by any Underwriter whose funds have not been received by Howe Barnes Investments, Inc. by the relevant Time of Delivery but such
payment shall not relieve such Underwriter from its obligations hereunder. 
 4. Upon the authorization by the Representative of the release
of the Firm Shares, the several Underwriters propose to offer the Firm Shares for sale upon the terms and conditions set forth in the Prospectus. 
 5. (a) The Shares to be purchased by each Underwriter hereunder, in 
  

 - 15 - 

 definitive form, and in such authorized denominations and registered in such names as the Representative may request upon
at least forty-eight hours prior notice to the Company, shall be delivered by or on behalf of the Company to the Representative, through the facilities of the Depository Trust Company (“DTC”), for the account of such Underwriter, against
payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal (same day) funds to the account specified by the Company, to the Representative at least forty-eight hours in advance. The Company will cause the
certificates representing the Shares to be made available for checking and packaging at least twenty-four hours prior to the Time of Delivery (as defined below) with respect thereto at the office of DTC or its designated custodian (the
“Designated Office”). The time and date of such delivery and payment shall be, with respect to the Firm Shares, 9:30 a.m., Chicago Time, on July 5, 2006 or such other time and date as the Representative and the Company may agree upon
in writing, and, with respect to the Optional Shares, 9:30 a.m., Chicago time, on the date specified by the Representative in the written notice given by the Representative of the Underwriters’ election to purchase such Optional Shares, or such
other time and date as the Representative and the Company may agree upon in writing. Such time and date for delivery of the Firm Shares is herein called the “First Time of Delivery,” such time and date for delivery of the Optional Shares,
if not the First Time of Delivery, is herein called the “Second Time of Delivery,” and each such time and date for delivery is herein called a “Time of Delivery.” 
 (b) The documents to be delivered at each Time of Delivery, or at such time as otherwise to be delivered in accordance with the Representative’s
instructions, by or on behalf of the parties hereto pursuant to Section 8 hereof, including the cross receipt for the Shares and any additional documents requested by the Underwriters pursuant to Section 8(k) hereof, will be delivered at
the offices of Howe Barnes Investments, Inc., 222 South Riverside Plaza, 7th Floor, Chicago, Illinois 60606 (the
“Closing Location”), and the Shares will be delivered at the Designated Office, all at such Time of Delivery. A meeting will be held at the Closing Location at 2:00 p.m., Chicago Time, on the Chicago Business Day next preceding such Time
of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to the preceding sentence will be available for review by the parties hereto. For the purposes of this Section 5, “Chicago Business Day” shall
mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in Chicago are generally authorized or obligated by law or executive order to close. 
 6. The Company agrees with each of the Underwriters: 
 (a) To prepare the Prospectus in a form approved by the Representative and to file such Prospectus pursuant to Rule 424(b) under the Act not later than the Commission’s close of business on the second business day following the
execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by Rule 430A(a)(3) under the Act; to make no further amendment or any supplement to the Registration Statement or Prospectus which shall be disapproved
by the Representative promptly after reasonable notice thereof; to advise the Representative, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any
supplement to the Prospectus or any amended Prospectus has been filed and to furnish the Representative with copies thereof; to advise the Representative, promptly after it 
  

 - 16 - 

 receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the
use of any Preliminary Prospectus, Issuer-Represented Free Writing Prospectus or Prospectus, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any
such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement, any Preliminary Prospectus, any Issuer-Represented Free Writing Prospectus or Prospectus or for additional information; and, in the
event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, Issuer-Represented Free Writing Prospectus or Prospectus or suspending any such qualification, promptly to use its best efforts
to obtain the withdrawal of such order; 
 (b) If at any time following issuance of an Issuer-Represented Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer-Represented Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or included or would include an untrue
statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading, the Company has notified or will
notify promptly the Representative so that any use of such Issuer-Represented Free Writing Prospectus may cease until it is amended or supplemented and the Company has promptly amended or will promptly amend or supplement such Issuer-Represented
Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission; provided, however, that this covenant shall not apply to any statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Company by an Underwriter through the Representative expressly for use therein; 
 (c) The Company represents and
agrees that, unless it obtains the prior written consent of the Representative, and each Underwriter represents and agrees that, unless it obtains the prior written consent of each of the Company and the Representative, it has not made and will not
make any offer relating to the Shares that would constitute an “issuer free writing prospectus,” as defined in Rule 433 under the Act, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 under
the Act, required to be filed with the Commission. Any such free writing prospectus consented to by the Company and the Representative is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents that it has
treated or agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free
Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. The Company represents that it has satisfied the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic
road show; 
 (d) Promptly from time to time to take such action as the Representative may reasonably request to qualify the Shares for
offering and sale under the securities laws of such jurisdictions as the Representative may request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to
complete the distribution of the Shares, provided that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction; 
  

 - 17 - 

 (e) Prior to 10:00 a.m., Chicago Time, on the Chicago Business Day next succeeding the date of this
Agreement and from time to time, to furnish the Underwriters with copies of the Prospectus in Chicago in such quantities as the Representative may from time to time reasonably request, and, if the delivery of a prospectus is required at any time
prior to the expiration of nine months after the time of issue of the Prospectus in connection with the offering or sale of the Shares and if at such time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is delivered,
not misleading, or, if for any other reason it shall be necessary during such period to amend or supplement the Prospectus in order to comply with the Act, to notify the Representative and upon the Representative’s request to prepare and
furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representative may from time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or
omission or effect such compliance, and in case any Underwriter is required to deliver a prospectus in connection with sales of any of the Shares at any time nine months or more after the time of issue of the Prospectus, upon the
Representative’s request but at the expense of such Underwriter, to prepare and deliver to such Underwriter as many copies as the Representative may request of an amended or supplemented Prospectus complying with Section 10(a)(3) of the
Act; 
 (f) To make generally available to its securityholders as soon as practicable, but in any event not later than eighteen months after
the effective date of the Registration Statement (as defined in Rule 158(c) under the Act), an earning statement of the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Act and the rules and
regulations thereunder (including, at the option of the Company, Rule 158); 
 (g) During the period beginning from the date hereof and
continuing to and including the date 180 days after the date of the Prospectus, not to, and not to allow any of its directors or executive officers to, offer, sell, agree to sell, contract to sell hypothecate, pledge, grant any option to purchase,
make any short sale, or otherwise dispose of or hedge, directly or indirectly, except as provided hereunder any securities of the Company that are substantially similar to the Shares, including, but not limited to, any securities that are
convertible into or exchangeable for, or that represent the right to receive, stock or any such substantially similar securities (other than pursuant to employee stock option plans existing on, or upon the conversion or exchange of convertible or
exchangeable securities outstanding as of, the date of this Agreement) or publicly announce an intention to effect any such transaction, without the Representative’s prior written consent; provided, however, that if: (1) during the last
17 days of such 180-day period the Company issues an earnings release or material news or a material event relating to the Company occurs; or (2) prior to the expiration of such 180-day period, the Company announces that it will release
earnings results during the 16-day-period beginning on 
  

 - 18 - 

 the last day of such 180-day period, the restrictions imposed by this Section 6(g) shall continue to apply until the
expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event; 
 (h) To furnish to its securityholders, as soon as practicable after the end of each fiscal year, an annual report (including a balance sheet and statements of income, stockholders’ equity and cash flows of the Company and its
consolidated subsidiaries certified by an independent registered public accounting firm) and, as soon as practicable after the end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the effective
date of the Registration Statement), to make available to its securityholders consolidated summary financial information of the Company and its subsidiaries for such quarter in reasonable detail; 
 (i) During a period of five years from the effective date of the Registration Statement, to furnish to the Representative copies of all reports or other
communications (financial or other) furnished to stockholders, and to deliver to the Representative (i) as soon as they are available, copies of any reports and financial statements furnished to or filed with the Commission or any national
securities exchange on which any class of securities of the Company is listed; and (ii) such additional information concerning the business and financial condition of the Company as the Representative may from time to time reasonably request
(such financial statements to be on a consolidated basis to the extent the accounts of the Company and its subsidiaries are consolidated in reports furnished to its securityholders generally or to the Commission); 
 (j) To use the net proceeds received by it from the sale of the Shares pursuant to this Agreement in the manner specified in each of the General
Disclosure Package and the Prospectus under the caption “Use of Proceeds”; 
 (k) If the Company elects to rely on Rule 462(b), the
Company shall file a Rule 462(b) Registration Statement with the Commission in compliance with Rule 462(b) by 10:00 p.m., Chicago time, on the date of this Agreement, and the Company shall at the time of filing either pay to the Commission the
filing fee for the Rule 462(b) Registration Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 111(b) under the Act; 
 (l) To use its best efforts to list for quotation the Shares on the National Market of the National Association of Securities Dealers Automated Quotations System (“NASDAQ”); 
 (m) During the period beginning on the date hereof and ending on the later of the fifth anniversary of the First Time of Delivery or the date on which
the Underwriters receive full payment in satisfaction of any claim for indemnification or contribution to which they may be entitled pursuant to Section 9 of this Agreement, neither the Company nor the Banks shall, without the prior written
consent of the Representative, take or permit to be taken any action that could result in the Company’s or the Banks’ common stock becoming subject to any security interest, mortgage, pledge, lien or encumbrance; provided,
however, that this 
  

 - 19 - 

 covenant shall be null and void if the FRB, the North Carolina Commissioner of Banks, the FDIC, or any other federal or
state agency having jurisdiction over the Banks, by regulation, policy statement or interpretive release or by written order or written advice addressed to the Banks and specifically addressing the provisions of Section 9 hereof, permits
indemnification of the Underwriters by the Banks as contemplated by such provisions; 
 (n) To file with the Commission such information on
Form 10-K or Form 10-Q as may be required by Rule 463 under the Act; and 
 (o) To comply, and to use its best efforts to cause the
Company’s directors and officers, in their capacities as such, to comply, in all material respects, with all effective applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations thereunder. 
 7. The Company covenants and agrees with the several Underwriters that the Company will pay or cause to be paid the following: (i) in the event that
the offering is not closed by December 31, 2006 (for reasons other than the Underwriters failing to abide by the terms of this Underwriting Agreement), one-half of Underwriters’ counsel fees and expenses, such reimbursement amount not to
exceed $30,000; (ii) the fees, disbursements and expenses of the Company’s counsel and accountants in connection with the registration of the Shares under the Act and all other expenses in connection with the preparation, printing and
filing of the Registration Statement, any Preliminary Prospectus, any Permitted Free Writing Prospectus and the Prospectus and amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers;
(iii) the cost of printing or producing any agreement among Underwriters, this Agreement, the Blue Sky Memorandum, closing documents (including any compilations thereof) and any other documents in connection with the offering, purchase, sale
and delivery of the Shares; (iv) all expenses in connection with the qualification of the Shares for offering and sale under state securities laws, including the fees and disbursements of counsel for the Underwriters in connection with such
qualification and in connection with the Blue Sky survey; (v) all fees and expenses in connection with listing the Shares on NASDAQ; (vi) the filing fees incident to, and the fees and disbursements of counsel for the Underwriters in
connection with, securing any required review by the National Association of Securities Dealers, Inc. of the terms of the sale of the Shares; (vii) the cost of preparing stock certificates; (viii) the cost and charges of any transfer agent
or registrar; and (ix) all other costs and expenses incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section. 
 8. The obligations of the Underwriters hereunder, as to the Shares to be delivered at each Time of Delivery, shall be subject, in their discretion, to
the condition that all representations and warranties and other statements of the Company herein are, at and as of such Time of Delivery, true and correct, the condition that the Company shall have performed all of its obligations hereunder
theretofore to be performed, and the following additional conditions: 
 (a) The Prospectus shall have been filed with the Commission
pursuant to Rule 424(b) within the applicable time period prescribed for such filing by the rules 
  

 - 20 - 

 and regulations under the Act and in accordance with Section 6(a) hereof (or a post-effective amendment shall have
been filed and declared effective in accordance with the requirements of Rule 430A); if the Company has elected to rely upon Rule 462(b), the Rule 462(b) Registration Statement shall have become effective by 10:00 p.m., Chicago Time, on the
date of this Agreement; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; and all
requests for additional information on the part of the Commission shall have been complied with to the Representative’s reasonable satisfaction; and the NASD shall have raised no objection to the fairness and reasonableness of the underwriting
terms and arrangements; 
 (b) Nelson Mullins Riley & Scarborough LLP, counsel for the Underwriters, shall have furnished to the
Representative such written opinion or opinions, dated as of such Time of Delivery, with respect to the incorporation of the Company, the validity of the Shares, the Registration Statement, the Prospectus as amended or supplemented and other related
matters as the Representative may reasonably request, and such counsel shall have received such papers and information as they may reasonably request to enable them to pass upon such matters; 
 (c) Gaeta & Eveson, P.A., counsel for the Company, shall have furnished to the Representative their written opinion (a draft of such opinion is
attached as Annex II hereto), dated such Time of Delivery, in form and substance satisfactory to the Representative, to the effect set forth in Annex II hereto and to such further effect as counsel to the Underwriters may reasonably request;

 (d) On the date of the Prospectus at a time prior to the execution of this Agreement, at 9:30 a.m., Chicago Time, on the effective date of
any post-effective amendment to the Registration Statement filed subsequent to the date of this Agreement and also at each Time of Delivery, Dixon Hughes PLLC shall have furnished to the Representative a letter or letters, dated the respective dates
of delivery thereof, in form and substance satisfactory to the Representative, to the effect set forth in Annex I hereto (the executed copy of the letter delivered prior to the execution of this Agreement is attached as Annex I(a) hereto and a
draft of the form of letter to be delivered on the effective date of any post-effective amendment to the Registration Statement and as of each Time of Delivery is attached as Annex I(b) hereto); 
 (e) (i) Neither the Company nor any of its subsidiaries shall have sustained since the date of the latest audited financial statements included in each
of the General Disclosure Package and the Prospectus any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or
decree, otherwise than as set forth or contemplated in the Prospectus, and (ii) since the respective dates as of which information is given in each of the General Disclosure Package and the Prospectus there shall not have been any change in the
capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting the general affairs, management, financial position, stockholders’ equity or results of
operations of the Company and its subsidiaries, otherwise than as set forth or contemplated in each of the General 
  

 - 21 - 

 Disclosure Package and the Prospectus, the effect of which, in any such case described in Clause (i) or (ii), is in
the judgment of the Representative so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Time of Delivery on the terms and in the manner
contemplated in each of the General Disclosure Package and the Prospectus; 
 (f) On or after the date hereof (i) no downgrading shall
have occurred in the rating accorded the Company’s debt securities by any “nationally recognized statistical rating organization”, as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Act, and
(ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company’s debt securities; 
 (g) On or after the date hereof there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities
generally on the New York Stock Exchange or on NASDAQ; (ii) a suspension or material limitation in trading in the Company’s securities on NASDAQ; (iii) a general moratorium on commercial banking activities declared by either Federal,
or New York, Georgia, North Carolina, or Illinois authorities; or (iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war or a material adverse change in
general economic, political or financial conditions, including without limitation as a result of terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United States shall be such), or
any other calamity or crisis, if the effect of any such event specified in this Clause (iv) in the judgment of the Representative makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being
delivered at such Time of Delivery on the terms and in the manner contemplated in the Prospectus; 
 (h) The Shares to be sold at such Time
of Delivery shall have been duly listed for quotation on NASDAQ; 
 (i) The Company has obtained and delivered to the Underwriters executed
copies of an agreement from the stockholders listed on Schedule II hereto, substantially to the effect set forth in Section 6(g) hereof in form and substance satisfactory to the Representative; 
 (j) The Company shall have complied with the provisions of Section 5(b) hereof with respect to the furnishing of prospectuses as delivered in
accordance with the Representative’s instructions; and 
 (k) The Company shall have furnished or caused to be furnished to the
Representative at such Time of Delivery certificates of officers of the Company satisfactory to the Representative as to the accuracy of the representations and warranties of the Company herein at and as of such Time of Delivery, as to the
performance by the Company of all of its obligations hereunder to be performed at or prior to such Time of Delivery, as to the matters set forth in subsections (a) and (e) of this Section and as to such other matters as the Representative
may reasonably request. 
  

 - 22 - 

 9. (a) The Company and the Banks, jointly and severally, shall indemnify and hold harmless each
Underwriter against any losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Registration Statement, the General Disclosure Package, the Prospectus or any individual
Issuer-Represented Limited-Use Free Writing Prospectus, when considered together with the General Disclosure Package, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each such indemnified party for any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such action or claim as such expenses are incurred; provided, however, that neither the Company nor the Banks shall be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon
an untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, the Registration Statement, the General Disclosure Package, the Prospectus or any individual Issuer-Represented Limited-Use Free
Writing Prospectus, when considered together with the General Disclosure Package, or any such amendment or supplement in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the Representative
expressly for use therein (provided that the Company and the Underwriters hereby acknowledge and agree that the only information that the Underwriters have furnished to the Company specifically for inclusion in any Preliminary Prospectus, the
Registration Statement, the General Disclosure Package, the Prospectus or any individual Issuer-Represented Limited-Use Free Writing Prospectus, when considered together with the General Disclosure Package, or any amendment or supplement thereto,
are (i) the concession and reallowance figures appearing in the Prospectus in the section entitled “Underwriting,” (ii) the section entitled “Underwriting” relating to the Underwriters’ reservation of the right to
withdraw, cancel or modify the offer contemplated by this Agreement and to reject orders in whole or in part, and (iii) the section entitled “Underwriting” relating to stabilization transactions, over-allotment transactions, syndicate
covering transactions and penalty bids in which the Underwriters may engage (collectively, the “Underwriters’ Information”). Notwithstanding the foregoing, the indemnification provided for in this paragraph (a) shall not apply to
the Banks to the extent that such indemnification by the Banks is found in a final judgment by a court of competent jurisdiction to constitute a covered transaction under Section 23A of the Federal Reserve Act. 
 (b) Each Underwriter shall indemnify and hold harmless the Company against any losses, claims, damages or liabilities to which the Company may become
subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in any
Preliminary Prospectus, the Registration Statement, the General Disclosure Package, the Prospectus, or any individual Issuer-Represented Limited-Use Free Writing Prospectus, when considered together with the General Disclosure Package, or any
amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the 
  

 - 23 - 

 statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or
alleged untrue statement or omission or alleged omission was made in any Preliminary Prospectus, the Registration Statement, the General Disclosure Package, the Prospectus or any individual Issuer-Represented Limited-Use Free Writing Prospectus,
when considered together with the General Disclosure Package, or any such amendment or supplement, in reliance upon and in conformity with written information furnished to the Company by such Underwriter through the Representative expressly for use
therein; and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred. 
 (c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such
indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party
shall not relieve it from any liability which it may have to any indemnified party otherwise than under such subsection. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to
such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof,
the indemnifying party shall not be liable to such indemnified party under such subsection for any legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense
thereof other than reasonable costs of investigation. No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or
threatened action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment
(i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of
any indemnified party. 
 (d) If the indemnification provided for in this Section 9 is unavailable to or insufficient to hold harmless
an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the
Underwriters on the other from the offering of the Shares. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law or if the indemnified party failed to give the notice required under subsection
(c) above, then each indemnifying party shall contribute to such amount paid or payable by such 
  

 - 24 - 

 indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative
fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received
by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the Underwriters on the other and the
parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this
subsection (d) were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to
above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (d) shall be deemed to include any
legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to contribute any
amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Underwriters’ obligations in this subsection (d) to contribute are several in proportion to their respective underwriting obligations and not joint. 
 (e) The obligations of the Company and the Banks under this Section 9 shall be in addition to any liability which the Company and the Banks may
otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls (within the meaning of the Act) any Underwriter, or any of the respective partners, directors, officers and employees of any Underwriter or any
such controlling person; and the obligations of the Underwriters under this Section 9 shall be in addition to any liability which the respective Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each
director of the Company (including any person who, with his or her consent, is named in the Registration Statement as about to become a director of the Company), each officer of the Company who signs the Registration Statement and to each person, if
any, who controls the Company or the Banks, as the case may be, within the meaning of the Act. 
 10. (a) If any Underwriter shall default in
its obligation to purchase the Shares which it has agreed to purchase hereunder at a Time of Delivery, the Representative may in the Representative’s discretion arrange for the Representative or another party or other parties 
  

 - 25 - 

 to purchase such Shares on the terms contained herein. If within thirty-six hours after such default by any Underwriter
the Representative does not arrange for the purchase of such Shares, then the Company shall be entitled to a further period of thirty-six hours within which to procure another party or other parties satisfactory to the Representative to purchase
such Shares on such terms. In the event that, within the respective prescribed periods, the Representative notifies the Company that the Representative have so arranged for the purchase of such Shares, or the Company notifies the Representative that
it has so arranged for the purchase of such Shares, the Representative or the Company shall have the right to postpone such Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary
in the Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any amendments to the Registration Statement or the Prospectus which in the Representative’s opinion may thereby
be made necessary. The term “Underwriter” as used in this Agreement shall include any person substituted under this Section with like effect as if such person had originally been a party to this Agreement with respect to such Shares.

 (b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the
Representative and the Company as provided in subsection (a) above, the aggregate number of such Shares which remains unpurchased does not exceed one-tenth of the aggregate number of all the Shares to be purchased at such Time of Delivery, then
the Company shall have the right to require each non-defaulting Underwriter to purchase the number of shares which such Underwriter agreed to purchase hereunder at such Time of Delivery and, in addition, to require each non-defaulting Underwriter to
purchase its pro rata share (based on the number of Shares which such Underwriter agreed to purchase hereunder) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall
relieve a defaulting Underwriter from liability for its default. 
 (c) If, after giving effect to any arrangements for the purchase of the
Shares of a defaulting Underwriter or Underwriters by the Representative and the Company as provided in Section 10(a) hereof, the aggregate number of such Shares which remains unpurchased exceeds one-tenth of the aggregate number of all the
Shares to be purchased at such Time of Delivery, or if the Company shall not exercise the right described in Section 10(b) hereof to require non-defaulting Underwriters to purchase Shares of a defaulting Underwriter or Underwriters, then this
Agreement (or, with respect to the Second Time of Delivery, the obligations of the Underwriters to purchase and of the Company to sell the Optional Shares) shall thereupon terminate, without liability on the part of any non-defaulting Underwriter or
the Company, except for the expenses to be borne by the Company as provided in Section 7 hereof and the indemnity and contribution agreements in Section 9 hereof; but nothing herein shall relieve a defaulting Underwriter from liability for
its default. 
 11. The respective indemnities, agreements, representations, warranties and other statements of the Company and the several
Underwriters, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on

  

 - 26 - 

 behalf of any Underwriter or any controlling person of any Underwriter, or the Company, or any officer or director or
controlling person of the Company, and shall survive delivery of and payment for the Shares. 
 12. If this Agreement is terminated pursuant
to Section 10 hereof, neither the Company nor the Banks shall then be under any liability to any Underwriter except as provided in Sections 7 (in the case of the Company) and 9 (in the case of the Company and the Banks) hereof; but, if for
any other reason, any Shares are not delivered by or on behalf of the Company as provided herein, the Company will reimburse the Underwriters through the Representative for all out-of-pocket expenses, including fees and disbursements of counsel,
incurred by the Underwriters in connection with the transactions contemplated hereby, including, without limitation, marketing, syndication and travel expenses incurred by the Underwriters in making preparations for the purchase, sale and delivery
of the Shares not so delivered, but the Company shall then be under no further liability to any Underwriter except as provided in Sections 7 and 9 hereof. 
 13. In all dealings hereunder, the Representative shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of
any Underwriter made or given by the Representative. 
 All statements, requests, notices and agreements hereunder shall be in writing, and
if to the Underwriters shall be delivered or sent by mail, telex or facsimile transmission to the Representative at 222 South Riverside Plaza, 7th Floor, Chicago, Illinois 60606, Attention: General Counsel; and if to the Company or to the Banks shall be delivered or sent by mail to the address of the Company set forth in the Registration
Statement, Attention: John Q. Shaw, Jr.; provided, however, that any notice to an Underwriter pursuant to Section 9(c) hereof shall be delivered or sent by mail or facsimile transmission to such Underwriter at its address or facsimile number
set forth in its Underwriters’ Questionnaire, which address or facsimile number will be supplied to the Company by the Representative upon request. Any such statements, requests, notices or agreements shall take effect upon receipt thereof.

 14. This Agreement and the Pricing Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters, the Company, the
Banks and, to the extent provided in Sections 9 and 11 hereof, the officers and directors of the Company and of the Banks and each person who controls the Company, the Banks or any Underwriter, and their respective heirs, executors, administrators,
successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. No purchaser of any of the Shares from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.

 15. Time shall be of the essence of this Agreement and the Pricing Agreement. As used herein, the term “business day” shall mean
any day when the Commission’s office in Washington, D.C. is open for business. 
 16. This Agreement and the Pricing Agreement shall be
governed by and construed in accordance with the laws of the State of Illinois. 
  

 - 27 - 

 17. This Agreement and the Pricing Agreement may be executed by any one or more of the parties hereto in
any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. 
 If the foregoing is in accordance with your understanding, please sign and return to us four counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Underwriters, this letter and such
acceptance hereof shall constitute a binding agreement between each of the Underwriters, the Company and the Banks. 
  

			
	 Very truly yours,

	
	 NEW CENTURY BANCORP, INC.

		
	 By:
	 	 /s/ John Q. Shaw, Jr.

	 Name:
	 	 John Q. Shaw, Jr.

	 Title:
	 	 Chief Executive Officer

	
	 NEW CENTURY BANK

		
	 By:
	 	 /s/ John Q. Shaw, Jr.

	 Name:
	 	 John Q. Shaw, Jr.

	 Title:
	 	 Chief Executive Officer

	
	 NEW CENTURY BANK SOUTH

		
	 By:
	 	 /s/ William L. Hedgepeth

	 Name:
	 	 William L. Hedgepeth

	 Title:
	 	 Chief Executive Officer

 [Signatures continued on following page] 
  

 - 28 - 

 Accepted as of the date hereof: 
  

	HOWE	BARNES INVESTMENTS, INC. 

     As Representative of the Several Underwriters 
             named in Schedule I hereto 
  

			
	 By:   
	 	HOWE BARNES INVESTMENTS, INC.
		
	By:	 	 /s/ Daniel E. Coughlin

	Name:	 	Daniel E. Coughlin
	Title:	 	President and Chief Executive Officer

  

 - 29 - 

 SCHEDULE I 
  

					
	 Underwriter
	  	 Total Number of
 Firm Shares
 to be
Purchased
	  	 Number of Optional
 Shares to be
 Purchased
if
 Maximum Option
 Exercised

	 Howe Barnes Investments, Inc.
	  		  	
	 Sandler O’Neill & Partners, L.P.
	  		  	
	 Total
	  	1,000,000	  	150,000

 SCHEDULE II 
 Certain Stockholders 

 ANNEX I 
 Pursuant to Section 8(d) of the Underwriting Agreement, the accountants shall furnish letters to the Underwriters to the effect that: 
 (i) They are independent certified public accountants with respect to the Company and its subsidiaries within the meaning of the Act and the applicable published rules and regulations thereunder; 
 (ii) In their opinion, the financial statements and any supplementary financial information and schedules (and, if applicable, financial forecasts
and/or pro forma financial information) examined by them and included in the Prospectus or the Registration Statement comply as to form in all material respects with the applicable accounting requirements of the Act and the related published rules
and regulations thereunder; and, if applicable, they have made a review in accordance with standards established by the American Institute of Certified Public Accountants of the unaudited consolidated interim financial statements, selected financial
data, pro forma financial information, financial forecasts and/or condensed financial statements derived from audited financial statements of the Company for the periods specified in such letter, as indicated in their reports thereon, copies of
which have been separately furnished to the representative of the Underwriters (the “Representative”) and are attached hereto; 
 (iii) They have made a review in accordance with standards established by the American Institute of Certified Public Accountants of the unaudited condensed consolidated statements of income, consolidated balance sheets and consolidated
statements of cash flows included in the Prospectus as indicated in their reports thereon copies of which have been separately furnished to the Representative and are attached hereto; and on the basis of specified procedures including inquiries of
officials of the Company who have responsibility for financial and accounting matters regarding whether the unaudited condensed consolidated financial statements referred to in paragraph (vi)(A)(i) below comply as to form in all material respects
with the applicable accounting requirements of the Act and the related published rules and regulations, nothing came to their attention that causes them to believe that the unaudited condensed consolidated financial statements do not comply as to
form in all material respects with the applicable accounting requirements of the Act and the related published rules and regulations; 
 (iv) The unaudited selected financial information with respect to the consolidated results of operations and financial position of the Company for the five most recent fiscal years included in the Prospectus agrees with the corresponding
amounts (after restatement where applicable) in the audited consolidated financial statements for such five fiscal years; 
 (v) They have
compared the information in the Prospectus under selected captions with the disclosure requirements of Regulation S-K and on the basis of limited procedures specified in such letter nothing came to their attention as a result of the foregoing
procedures that caused them to believe that this information does not conform in all material respects with the disclosure requirements of Items 301, 302, 402 and 503(d), respectively, of Regulation S-K; 

 (vi) On the basis of limited procedures, not constituting an examination in accordance with generally
accepted auditing standards, consisting of a reading of the unaudited financial statements and other information referred to below, a reading of the latest available interim financial statements of the Company and its subsidiaries, inspection of the
minute books of the Company and its subsidiaries since the date of the latest audited financial statements included in the Prospectus, inquiries of officials of the Company and its subsidiaries responsible for financial and accounting matters and
such other inquiries and procedures as may be specified in such letter, nothing came to their attention that caused them to believe that: 
 (A) (i) the unaudited consolidated statements of income, consolidated balance sheets and consolidated statements of cash flows included in the Prospectus do not comply as to form in all material respects with the applicable accounting
requirements of the Act and the related published rules and regulations, or (ii) any material modifications should be made to the unaudited condensed consolidated statements of income, consolidated balance sheets and consolidated statements of
cash flows included in the Prospectus, for them to be in conformity with generally accepted accounting principles; 
 (B) any other unaudited
income statement data and balance sheet items included in the Prospectus do not agree with the corresponding items in the unaudited consolidated financial statements from which such data and items were derived, and any such unaudited data and items
were not determined on a basis substantially consistent with the basis for the corresponding amounts in the audited consolidated financial statements included in the Prospectus; 
 (C) the unaudited financial statements which were not included in the Prospectus but from which were derived any unaudited condensed financial statements
referred to in Clause (A) and any unaudited income statement data and balance sheet items included in the Prospectus and referred to in Clause (B) were not determined on a basis substantially consistent with the basis for the audited
consolidated financial statements included in the Prospectus; 
 (D) any unaudited pro forma consolidated condensed financial statements
included in the Prospectus do not comply as to form in all material respects with the applicable accounting requirements of the Act and the published rules and regulations thereunder or the pro forma adjustments have not been properly applied to the
historical amounts in the compilation of those statements; 
 (E) as of a specified date not more than five days prior to the date of such
letter, there have been any changes in the consolidated capital stock (other than issuances of capital stock upon exercise of options and stock appreciation rights, upon earn-outs of performance shares and upon conversions of convertible securities,
in each case which were outstanding on the date of the latest balance sheet included in the Prospectus) or any 
  

 - 2 - 

 increase in the consolidated long-term debt of the Company and its subsidiaries, or any decreases in
consolidated net current assets or stockholders= equity or other items specified by the Representative, or any increases in any items specified by the Representative, in each case as compared with amounts shown in the latest balance sheet included
in the Prospectus, except in each case for changes, increases or decreases which the Prospectus discloses have occurred or may occur or which are described in such letter; and 
 (F) for the period from the date of the latest financial statements included in the Prospectus to the specified date referred to in Clause (E) there
were any decreases in consolidated net revenues or operating profit or the total or per share amounts of consolidated net income or other items specified by the Representative, or any increases in any items specified by the Representative, in each
case as compared with the comparable period of the preceding year and with any other period of corresponding length specified by the Representative, except in each case for increases or decreases which the Prospectus discloses have occurred or may
occur or which are described in such letter; and 
 (vii) In addition to the examination referred to in their report(s) included in the
Prospectus and the limited procedures, inspection of minute books, inquiries and other procedures referred to in paragraphs (iii) and (vi) above, they have carried out certain specified procedures, not constituting an examination in
accordance with generally accepted auditing standards, with respect to certain amounts, percentages and financial information specified by the Representative which are derived from the general accounting records of the Company and its subsidiaries,
which appear in the Prospectus or in Part II of, or in exhibits and schedules to, the Registration Statement specified by the Representative and have compared certain of such amounts, percentages and financial information with the accounting records
of the Company and its subsidiaries and have found them to be in agreement. 
  

 - 3 - 

 ANNEX II 
 Opinion of Company Counsel 
 (i) The Company is a registered [bank] holding company under the [Bank
Holding Company Act of 1956, as amended]; has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of [State of Incorporation], with power and authority (corporate and other) to own its
properties and conduct its business as described in the Prospectus; 
 (ii) The Company has an authorized capitalization as set forth in the
Prospectus under the heading “Capitalization”, and all of the issued shares of capital stock of the Company (including the Shares being delivered at such Time of Delivery) have been duly and validly authorized and issued and are fully paid
and nonassessable; and the Shares conform to the description of the Shares contained in the Prospectus; 
 (iii) Except as described in the
Prospectus, (A) there are no outstanding rights (contractual or otherwise), warrants or options to acquire, or instruments convertible into or exchangeable for, or agreements or understandings with respect to the sale or issuance of, any shares
of capital stock of or other equity interest in the Company; and (B) there are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement
under the Act or otherwise register any securities of the Company owned or to be owned by such person; 
 (iv) The Company has been duly
qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, or is subject to
any liability or disability by reason of failure to be so qualified in any jurisdiction, except where such failure to be so qualified would not have a Material Adverse Effect; 
 (v) Each subsidiary of the Company either has been duly incorporated and is validly existing as a corporation or a statutory business trust or has been
duly chartered and is validly existing as a [Type of Bank], in each case in good standing under the laws of the jurisdiction of its organization, with power and authority (corporate and other) to own its properties and conduct its business as
described in the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as
to require such qualification, or is subject to no material liability or disability by reason of the failure to be so qualified in any such jurisdiction; the activities of the subsidiaries of the Banks are activities permitted to subsidiaries of a
[Type of Bank] under applicable law and the rules and regulations of the [OTS/OCC/State Bank Regulator] and the deposit accounts of the Banks are insured up to the applicable limits by the FDIC; all of the issued and outstanding capital stock of
each subsidiary of the Company has been duly authorized and validly issued and is fully paid and nonassessable, except to the extent set forth in Section 53-42 of the North Carolina General Statutes, and is owned, directly or through other
subsidiaries of the Company, by the Company free and clear of any pledge, lien, encumbrance, claim or equity; 
  

 - 4 - 

 (vi) To the best of such counsel’s knowledge, the Company and its subsidiaries have good and
marketable title to all real property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in the Prospectus or such as do not materially affect the value of such property and do not
interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries; 
 (vii) Except as disclosed in the Prospectus, the Company and its subsidiaries are conducting their respective businesses in compliance in all material
respects with all laws, rules, regulations, decisions, directives and orders (including, without limitation, all regulations and orders of, or agreements with, the FDIC, the FRB, the [OTS/OCC/State Bank Regulator], the Equal Credit Opportunity Act,
the Fair Housing Act, the Community Reinvestment Act, the Home Mortgage Disclosure Act and all other applicable fair lending laws or other laws relating to discrimination and the Bank Secrecy Act and Title III of the USA Patriot Act) and neither the
Company nor any of its subsidiaries has received any communication from any Governmental Entity asserting that the Company or any of its subsidiaries is not in material compliance with any statute, law, rule, regulation, decision, directive or
order; there is no action, suit, investigation or proceeding before or by any Governmental Entity now pending or, to the knowledge of such counsel, threatened or contemplated against or affecting the Company or any of its subsidiaries (A) that
is required to be disclosed in the Registration Statement and not disclosed therein, (B) that could result, individually or in the aggregate, in any Material Adverse Effect, (C) that could materially and adversely affect the properties,
assets or leasehold interests of the Company and its subsidiaries, considered as one enterprise, or (D) that could adversely affect the consummation of the transactions contemplated in this Agreement; all pending legal or governmental
proceedings to which the Company or any of its subsidiaries is a party or of which any of their property is the subject, which are not described in the Registration Statement, including ordinary routine litigation incidental to their respective
businesses, either individually or in the aggregate, would not have a Material Adverse Effect; 
 (viii) This Agreement has been duly
authorized, executed and delivered by the Company and the Banks; 
 (ix) The issue and sale of the Shares being delivered at such Time of
Delivery by the Company and the compliance by the Company with all of the provisions of this Agreement and the consummation of the transactions herein contemplated will not conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument known to such counsel to which the Company or any of its subsidiaries is a party or by which the 
  

 - 5 - 

 Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, nor will such action result in any violation of the provisions of the [Articles of Incorporation] or Bylaws of the Company or any statute or any order, rule or regulation known to such counsel of any court or Governmental
Entity; 
 (x) No consent, approval, authorization, order, registration or qualification of or with any court or Governmental Entity is
required for the issue and sale of the Shares or the consummation by the Company of the transactions contemplated by this Agreement, except the registration under the Act of the Shares, and except as may be required under the rules and regulations
of the NASD and such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Underwriters; 
 (xi) Neither the Company nor any of its subsidiaries is in violation of its certificate of incorporation or charter (as applicable) or bylaws or, to such
counsel’s knowledge, in default in the performance or observance of any material obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which
it is a party or by which it or any of its properties may be bound; 
 (xii) The statements set forth in the Prospectus under the caption
“Description of Capital Stock”, insofar as they purport to constitute a summary of the terms of the Shares and under the captions [“Regulation”] and “Underwriting”, insofar as they purport to describe the provisions of
the laws and documents referred to therein, are accurate and complete; 
 (xiii) To the best of such counsel’s knowledge, each of the
Company and its subsidiaries possess all Governmental Licenses and have made all filings, applications and registrations with all Governmental Entities that are required in order to permit the Company or such subsidiary to conduct its business as
presently conducted, except where the failure to possess such Governmental License or to have made such filing, application or registration would not, individually or in the aggregate, have a Material Adverse Effect; all of the Governmental Licenses
are valid and in full force and effect, except where the invalidity of such Governmental Licenses to be in full force and effect, individually or in the aggregate, would not have a Material Adverse Effect; and neither the Company nor any of its
subsidiaries has received any notice of proceedings relating to the revocation or modification of any such Governmental Licenses which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a
Material Adverse Effect; 
 (xiv) To the best of such counsel’s knowledge, neither the Company nor any of its subsidiaries is a party to
or subject to any order, decree, agreement, memorandum of understanding or similar arrangement with, or a commitment letter, supervisory letter or similar submission to, any Governmental Entity charged with the supervision or regulation of
depository institutions or engaged in the insurance of deposits (including the FDIC) or the supervision or regulation of it or any of its subsidiaries and neither the Company nor any of its subsidiaries has 
  

 - 6 - 

 been advised by any such Governmental Entity that such Governmental Entity is contemplating issuing or requesting (or is
considering the appropriateness of issuing or requesting) any such order, decree, agreement, memorandum of understanding, commitment letter, supervisory letter or similar submission; 
 (xv) The Company is not, and after giving effect to the offering and sale of the Shares, will not be, an “investment company” or an entity
“controlled” by an “investment company”, as such terms are defined in the Investment Company Act; 
 (xvi) The documents
incorporated by reference in the Prospectus (other than the financial statements and related schedules therein, as to which such counsel need express no opinion), when they were filed with the Commission, complied as to form in all material respects
with the requirements of the Exchange Act and the rules and regulations of the Commission thereunder; and they have no reason to believe that any such documents, when such documents were so filed, contained an untrue statement of a material fact or
omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such documents were so filed, not misleading; 
 (xvii) The Registration Statement and the Prospectus and any further amendments and supplements thereto made by the Company prior to such Time of
Delivery (other than the financial statements and related schedules therein, as to which such counsel need express no opinion) comply as to form in all material respects with the requirements of the Act and the rules and regulations thereunder; and
such counsel does not know of any contracts or other agreements of a character required to be incorporated by reference into the Prospectus or required to be filed as an exhibit to the Registration Statement or required to be described in the
Registration Statement or Prospectus which are not filed or incorporated by reference or described as required; 
 (xviii) The Company is in
compliance with the applicable provisions of the Sarbanes-Oxley Act, the rules and regulations of the Commission thereunder and the corporate governance and other rules and regulations of Nasdaq; 
 In addition, such counsel shall state that nothing has come to such counsel’s attention that would lead such counsel to believe that the Registration Statement
(except for financial statements and schedules and other financial or statistical data included therein, as to which counsel need make no statement), at the time it became effective, or that the General Disclosure Package as of the Applicable Time,
contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading or that the Prospectus or any further amendment or supplement thereto made
by the Company prior to such Time of Delivery (except for financial statements and schedules and other financial or statistical data included therein, as to which counsel need make no statement), at the time the Registration Statement became
effective and at such Time of Delivery, included or includes an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading. 
  

 - 7 - 

 EXHIBIT A 
 NEW CENTURY BANCORP, INC. 
 1,000,000 Shares Common Stock* 
 PRICING AGREEMENT 
 June 29, 2006 

Howe Barnes Investments, Inc. 
     As Representative
of the Several 
         Underwriters Named in Schedule I hereto 
 222 South Riverside Plaza 
 7th Floor

 Chicago, Illinois 60606 
 Ladies and Gentlemen: 
 Reference is made to the Underwriting Agreement dated June 29, 2006 (the
“Underwriting Agreement”) relating to the sale by the Company and the purchase by the several Underwriters for whom Howe Barnes Investments, Inc. is acting as Representative (the “Representative”), of the above
Shares. All terms herein shall have the definitions contained in the Underwriting Agreement except as otherwise defined herein. 
 Pursuant
to Section 3 of the Underwriting Agreement, the Company agrees with the Representatives as follows: 
 1. The initial public offering
price per share for the Shares shall be $18.50. 
 2. The purchase price per share for the Shares to be paid by the several
Underwriters shall be $17.575, being an amount equal to the initial public offering price set forth above less $.925 per share. 
 Schedule I is amended as follows: 
  

	*	Plus an option to acquire up to 150,000 additional shares to cover overallotments. 

  

 - 8 - 

 If the foregoing is in accordance with your understanding of our agreement, kindly sign and return to us
the enclosed duplicates hereof, whereupon it will become a binding agreement among the Company and the several Underwriters, including you, all in accordance with its terms. 
  

			
	Very truly yours,
	
	NEW CENTURY BANCORP, INC.
		
	By	 	 /s/ John Q. Shaw, Jr.

	Name:	 	John Q. Shaw. Jr.
	Title:	 	Chief Executive Officer

 The foregoing Agreement is hereby 
 confirmed and accepted as of the date first 
 above written. 
 HOWE BARNES INVESTMENTS, INC. 
 As Representative of the Several 
             Underwriters Named in Schedule I hereto 
  

			
	By:	 	HOWE BARNES INVESTMENTS, INC.
		
	By	 	 /s/ Daniel E. Coughlin

	Name:	 	Daniel E. Coughlin
	Title:	 	President and Chief Executive Officer

  

 - 9 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]